Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $5.26

Daily Change: +$0.22 / 4.18%

Daily Range: $5.04 - $5.30

Market Cap: $523,569,984

Daily Volume: 4,429

Performance Metrics

1 Week: 16.94%

1 Month: -3.45%

3 Months: 50.00%

6 Months: 3.49%

1 Year: 169.5%

YTD: 32.28%

Company Details

Employees: 71

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

ABVC BioPharma, Inc. (ABVC)

Redhill Biopharma Ltd. (RDHL)

Edgewise Therapeutics, Inc. (EWTX)